4.6 • 12 Ratings
🗓️ 4 March 2025
⏱️ 5 minutes
🧾️ Download transcript
Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an eye-popping $10.2 billion valuation. But it has yet to be paid for reviving extinct animals or saving endangered ones.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Click on a timestamp to play from that location
0:00.0 | Here's your Forbes Daily Briefing bonus story of the week. |
0:05.1 | Today on Forbes, meet the billionaire CEO trying to resurrect the woolly mammoth. |
0:12.0 | Serial entrepreneur Ben Lamb and Harvard geneticist George Church started colossal biosciences in 2021 |
0:19.3 | to bring back the woolly mammoth. |
0:22.1 | It's an idea that's equal parts crazy and brilliant, |
0:25.4 | with real-world implications for the environment, climate change, and even healthcare, |
0:29.9 | if they can pull it off. |
0:31.7 | With the company recently raising $200 million at a valuation of $10.2 billion, |
0:41.6 | led by TWG Global, CEO Lamb is now a billionaire, |
0:49.3 | worth $3.7 billion by Forbes's estimates. Church, who started work on the concept in his lab many years before it became a company, does not have an equity stake in colossal. Church said, quote, |
0:55.0 | the fact that I'm not a billionaire is almost as interesting as Ben being one. If I had a billion |
1:00.1 | dollars, I would just spend it on this. Church, who is 70 years old and known for his wild ideas, |
1:07.8 | had been working on sequencing the prehistoric woolly mammoths genome since around 2008. |
1:12.6 | Like many, he had an affection for big, furry, extinct creatures as a kid, but unlike most, he was also an expert in genomic sequencing. |
1:21.6 | In 1984, he developed the first genomic sequencing method, which resulted in the first genome sequence |
1:28.0 | for the human pathogen H. Pylori, which can cause stomach ulcers. He's also co-founded some |
1:34.2 | 50 biotech companies. Church's woolly mammoth dreams started off in his lab with little |
1:40.3 | thought of turning them into a business. The idea was so far out there that he didn't even bring it to investors. |
1:46.9 | Church said, quote, |
1:48.1 | I was so confident that no one would fund it that I didn't even ask. |
1:52.8 | After giving a talk in 2013, he received $100,000 from Peter Thiel. |
1:58.0 | It wasn't even close enough to support his research. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Forbes, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Forbes and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.